Southeastern Section of the American Urological Association SESAUA 2024

Viewing 1-20 of 21 articles

SESAUA 2024: Time Interval Between Radium-223 Therapy and 177Lu-PSMA Treatment for mCRPC and Outcomes in the RALU Study

SESAUA 2024: State of the Art Lecture: Management of Complications Following RPLND

SESAUA 2024: Addressing Racial Disparities in Prostate Cancer Prediction Models: External Validation and Comparison of Four Models of Pathological Outcome Prediction before Radical Prostatectomy

SESAUA 2024: Screening with PSA and MRI: Yearly Trends by PI-RADS and Race Shows Stable Diagnosis of NCCN Very Low Risk Disease

SESAUA 2024: Darolutamide in Combination with ADT and Docetaxel: Efficacy and Safety by Disease Volume and Risk in the Phase 3 ARASENS Trial

SESAUA 2024: Association of PSA Response and Overall Survival in Patients with mHSPC: Results from the Phase 3 ARASENS Trial

SESAUA 2024: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities

SESAUA 2024: Non-Narcotic Compliance and Clinical Outcomes in ERAS Cystectomy Patients

SESAUA 2024: Skeletal Muscle Changes in Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy

SESAUA 2024: Safety and Efficacy of Surgery in Metastatic and Non-Metastatic RCC with Supradiaphragmatic Tumor Thrombus Involving Cardiac Procedures

SESAUA 2024: Prognostic Significance of Pathologic Response to Neoadjuvant Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder with Variant Histology

SESAUA 2024: Determining the Genetic Causes of Bladder Cancer in a Family with Heritable Pattern of Bladder Cancer

SESAUA 2024: State of the Art Lecture: Digital Discounts for Urology Patients: Online Tools to Decrease Out-of-Pocket Prescription Costs

SESAUA 2024: Intravascular Heparinization During IVC Thrombectomy and Perioperative Complications

SESAUA 2024: Prevalence, Trends, and Costs of Office-Based and ASC-Based Diagnostic Cystoscopy in the United States

SESAUA 2024: Darolutamide, Enzalutamide, and Apalutamide for Non-Metastatic Castration-Resistance Prostate Cancer Patients in the United States (DEAR): Comparative Real-World Evidence

SESAUA 2024: Investigating the Role of Access to Quality Care for Muscle-Invasive Bladder Cancer in the Disparate Outcomes Among Sociodemographically Disadvantaged Patients in the State of Kentucky

SESAUA 2024: Impact of Rural Location on Receipt of Standard of Care Treatment and Survival for Locally Advanced Bladder Cancer in Louisiana

SESAUA 2024: Feasibility and Outcomes of Interventions to Reduce Cystoscopy Discomfort: A Quality Improvement Project

SESAUA 2024: A National Analysis Evaluating the Role of Lymph Node Dissection in Patients with High-Risk Upper Tract Urothelial Carcinoma

1
2